P

Inventor

XING XUECHAO

US53 patents
⚠️ This page may combine multiple inventors who share the name “XING XUECHAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ENANTA PHARM INC

48 patents
US10683279B2Jun 16, 2020

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC13 citations94
US11560368B2Jan 24, 2023

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC6 citations86
US11420976B2Aug 23, 2022

Heterocyclic compounds as anti-viral agents

ENANTA PHARM INC7 citations86
US11384090B2Jul 12, 2022

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC14 citations86
US11352363B1Jun 7, 2022

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC13 citations86
US11325916B1May 10, 2022

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC16 citations85
US10988458B2Apr 27, 2021

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC7 citations84
US10676500B2Jun 9, 2020

Process for preparation of sulfonyl carbamate bile acid derivatives

ENANTA PHARM INC7 citations84
US10457703B2Oct 29, 2019

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC8 citations84
US10450306B2Oct 22, 2019

Isoxazole analogs as FXR agonists and methods of use thereof

ENANTA PHARM INC7 citations84
US10450301B2Oct 22, 2019

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC11 citations84
US10253018B2Apr 9, 2019

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC10 citations84
US10246439B2Apr 2, 2019

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC12 citations84
US10208081B2Feb 19, 2019

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC9 citations84
US11919910B2Mar 5, 2024

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC5 citations74
US12018017B2Jun 25, 2024

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC1 citations73
US11958879B2Apr 16, 2024

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC1 citations73
US11834436B2Dec 5, 2023

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC2 citations73
US11718641B2Aug 8, 2023

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC1 citations73
US11040998B2Jun 22, 2021

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC2 citations73
US10968249B2Apr 6, 2021

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC3 citations73
US10696713B2Jun 30, 2020

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC3 citations73
US10472386B2Nov 12, 2019

Bile acid derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC6 citations73
US10149835B2Dec 11, 2018

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC2 citations73
US10080743B2Sep 25, 2018

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC4 citations73
US10080741B2Sep 25, 2018

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC3 citations73
US10080742B2Sep 25, 2018

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC3 citations73
US12552777B2Feb 17, 2026

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC0 citations63
US12459923B2Nov 4, 2025

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC0 citations63
US11034684B2Jun 15, 2021

Isoxazole analogs as FXR agonists and methods of use thereof

ENANTA PHARM INC1 citations63
US11008304B2May 18, 2021

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC1 citations63
US10829486B2Nov 10, 2020

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC1 citations63
US10689391B2Jun 23, 2020

Isoxazole analogs as FXR agonists and methods of use thereof

ENANTA PHARM INC2 citations63
US10597391B2Mar 24, 2020

Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC1 citations63
US10266560B2Apr 23, 2019

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC1 citations63
US10144729B2Dec 4, 2018

Isoxazole analogs as FXR agonists and methods of use thereof

ENANTA PHARM INC2 citations63
US12281140B2Apr 22, 2025

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC0 citations62
US10961272B2Mar 30, 2021

Process for preparation of sulfonyl carbamate bile acid derivatives

ENANTA PHARM INC0 citations62
US11976084B2May 7, 2024

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC0 citations52
US11945824B2Apr 2, 2024

Heterocyclic compounds as anti-viral agents

ENANTA PHARM INC0 citations52
US11555032B2Jan 17, 2023

Isoxazole derivatives as FXR agonists and methods of use thereof

ENANTA PHARM INC0 citations52
US11345699B2May 31, 2022

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC0 citations52
US10138228B2Nov 27, 2018

Isoxazole derivatives as FXR agonists and methods of use therof

ENANTA PHARM INC1 citations52
US12540141B2Feb 3, 2026

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC0 citations51
US12479854B2Nov 25, 2025

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC0 citations51
US12145942B2Nov 19, 2024

Spiropyrrolidine derived antiviral agents

ENANTA PHARM INC0 citations51
US12384753B2Aug 12, 2025

17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof

ENANTA PHARM INC0 citations50
US10519191B2Dec 31, 2019

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

ENANTA PHARM INC0 citations42

TUFTS COLLEGE

2 patents

Showing the top 50 of 53 patents by PatentIndex Score.